PubMed · 93544
Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.
Abstract
ST 1059, the pharmacologically active metabolite of midodrine, is a powerful vasoconstrictor compound, acting by stimulation of alpha-receptors. It elicited 80% of noradrenaline-induced contraction of human veins.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
O Thulesius, J E Gjöres, E Berlin. 1979. Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.. https://doi.org/10.1007/bf00568204
Cite the original work for its findings. Save a collection to share your selection of sources.